<DOC>
	<DOCNO>NCT02225886</DOCNO>
	<brief_summary>The administration ascorbic acid seem increase iron available erythropoiesis , thus improve anemia response treatment . The investigator therefore aim evaluate effect intravenous ascorbic acid administration hemodialysed patient iron overload .</brief_summary>
	<brief_title>Ascorbic Acid Administration Treatment Anemia Chronic Hemodialysed Patiens</brief_title>
	<detailed_description>Renal anemia complex condition chronic inflammation , among factor , change iron distribution lock deposit , also , iron metabolism parameter . Thus , hard separate iron functional deficit overload . The ascorbic acid hydrosoluble vitamin capable reduction hydrolysis . As reduction agent , ascorbic acid support transformation ferric iron ferrous iron . For instance , ascorbic acid increase digestive absorption take iron without transferrin , help iron release ferritin hemosiderin delay ferritin conversion hemosiderin ; therefore , administration ascorbic acid increase quantity iron available erythropoiesis realise deposit . Consequently , antioxidant function ascorbic acid increase red cell ' lifetime , reduce inflamation improve erythropoietin response Following premise , recent study examine effect administrate ascorbic acid hemodialysed patient erythropoiesis stimulate agent ( ESA ) hyporesponsiveness anemia functional deficit iron overload marker . The result administer ascorbic acid reveal increase level hemoglobin TSAT combine decrease ESA dose . The major limitation study short amount time observation ( &lt; 6months ) limit number participant hamper neither complete evaluation goal , adverse effect supplementary administration vitamin C. Until , Clinical practice guideline Kidney Disease recommend currently use high dos vitamin C , consider risk high level oxalemia limit information benefit . Considering background , intend evaluate benefit intravenous administration ascorbic acid hemodialysed patient iron balance marker suggestive iron overload .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>Age 18 year old At least 6 month hemodialysis time randomization ; Kt/Vâ‰¥1.2 ; 600 ng/mL last three determination serum ferritin AND 30 % growth last three determination transferin saturation ( TSAT ) Known active bleeding ( digestive , urinary , genital ) Parathyroid hormon , iPTH &gt; 800 pg/mL Neoplasia Hepatic B C viral infection C reactive protein ( CRP ) &gt; 12 mg/L Central venous catheter Severe liver cardiovascular disease ( decompensate ) , severe psichiatric disease disorder , accord study investigator , imply elimination study Malnutrition Acute infection HIV Other exist cause anemia except renal one Blood transfusion less thant 2 month first evaluation Epilepsy Pregnancy nurse Interpheron antiviral treatment one month initial evaluation Immunosuppresive treatment drug affect erythropoiesis one month initial evaluation Participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Renal anaemia</keyword>
	<keyword>Intravenous ascorbic acid</keyword>
	<keyword>Intravenous iron administration</keyword>
</DOC>